RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-11.86%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.23B
AUM Growth
+$1.23B
(-10%)
Cap. Flow
+$59M
Cap. Flow
% of AUM
4.8%
Top 10 Holdings %
Top 10 Hldgs %
29.04%
Holding
133
New
16
Increased
54
Reduced
20
Closed
13
Top Buys
| 1 |
STJ
St Jude Medical
STJ
|
$33.4M |
| 2 |
AET
Aetna Inc
AET
|
$25.1M |
| 3 |
Acadia Healthcare
ACHC
|
$19.9M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$18.4M |
| 5 |
CHMA
Chiasma, Inc. Common Stock
CHMA
|
$10.4M |
Top Sells
| 1 |
Medtronic
MDT
|
$42.2M |
| 2 |
THOR
THORATEC CORPORATION
THOR
|
$26.1M |
| 3 |
Humana
HUM
|
$25.2M |
| 4 |
McKesson
MCK
|
$14.7M |
| 5 |
Bausch Health
BHC
|
$13.7M |
Sector Composition
| 1 | Healthcare | 76.16% |
| 2 | Financials | 3.43% |
| 3 | Technology | 0.48% |
| 4 | Industrials | 0.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Acadia Healthcare
ACHC
$2.12B
| $53.8M | 4.37% | 812,000 +300,250 | +59% | +$19.9M |
|
|
AET
2
DELISTED
Aetna Inc
AET
| $42.2M | 3.43% | 386,000 +229,500 | +147% | +$25.1M |
|
3
AbbVie
ABBV
$372B
| $40.6M | 3.3% | 746,423 | – | – |
|
|
RDUS
4
DELISTED
Radius Health, Inc.
RDUS
| $38.8M | 3.15% | 560,000 +131,000 | +31% | +$9.08M |
|
5
HCA Healthcare
HCA
$94.5B
| $37.9M | 3.08% | 490,500 +68,000 | +16% | +$5.26M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $34.2M | 2.78% | 126,000 +4,500 | +4% | +$1.22M |
|
|
STJ
7
DELISTED
St Jude Medical
STJ
| $33.4M | 2.71% | +530,000 | New | +$33.4M |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $26.9M | 2.18% | 172,000 +17,500 | +11% | +$2.74M |
|
9
Gilead Sciences
GILD
$140B
| $25.3M | 2.05% | 257,500 | – | – |
|
10
Pfizer
PFE
$141B
| $23.9M | 1.94% | 760,000 | – | – |
|
|
MDCO
11
DELISTED
Medicines Co
MDCO
| $22.6M | 1.83% | 595,000 +249,500 | +72% | +$9.47M |
|
12
Collegium Pharmaceutical
COLL
$1.22B
| $22M | 1.78% | 994,400 +239,800 | +32% | +$5.3M |
|
|
CELG
13
DELISTED
Celgene Corp
CELG
| $21.4M | 1.74% | 198,000 | – | – |
|
|
EVHC
14
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $21M | 1.7% | 570,000 | – | – |
|
|
ONCE
15
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $20.9M | 1.69% | 500,000 -8,059 | -2% | -$336K |
|
|
16
Bausch Health
BHC
$2.74B
| $20.1M | 1.63% | 112,500 -76,750 | -41% | -$13.7M |
|
17
Eli Lilly
LLY
$657B
| $19.5M | 1.58% | 232,500 | – | – |
|
|
18
Teva Pharmaceuticals
TEVA
$21.1B
| $18.4M | 1.49% | +325,000 | New | +$18.4M |
|
|
TMH
19
DELISTED
Team Health Holdings Inc
TMH
| $17M | 1.38% | 315,000 +2,500 | +0.8% | +$135K |
|
20
Intuitive Surgical
ISRG
$170B
| $16.5M | 1.34% | 36,000 +3,000 | +9% | +$1.38M |
|
21
Cigna
CI
$80.3B
| $16.5M | 1.34% | 122,000 | – | – |
|
22
Neurocrine Biosciences
NBIX
$13.8B
| $14.9M | 1.21% | 374,000 -2,000 | -0.5% | -$79.6K |
|
|
ADPT
23
DELISTED
Adeptus Health Inc.
ADPT
| $14.4M | 1.17% | 178,000 +28,000 | +19% | +$2.26M |
|
|
HTWR
24
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $14.3M | 1.16% | 273,000 +111,000 | +69% | +$5.81M |
|
|
INOV
25
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $14.3M | 1.16% | 685,000 +125,000 | +22% | +$2.6M |
|